Literature DB >> 7672908

The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus.

M R van Cleeff1, H J Chum.   

Abstract

BACKGROUND: Routine data obtained from the National Tuberculosis and Leprosy Programme (NTLP) of Tanzania have shown a constant increase in the notified number of tuberculosis (TB) cases since 1982. Possible causes include an improved reporting system, improvement in health services after the introduction of short course chemotherapy (SCC), and human immunodeficiency virus (HIV) infection. This paper examines to what extent the increased TB case detection rate can be attributed to HIV infection, by calculating the population attributable risk for various years.
METHOD: The prevalence of HIV infection was obtained from data of the National AIDS Control Programme and the relative risk of HIV for developing TB from a case-control study and the literature.
RESULTS: Between 1985 and 1989 the increase was the highest among women aged 15-24 years and men aged 25-34 years; age groups in which HIV prevalence is highest. In the case-control study HIV prevalence among blood donors was 9.4% and among smear-positive pulmonary TB patients 51.6%, giving an odds ratio (OR) of 8.1 (95% confidence interval (CI): 4.4-16.3). For all TB cases the OR was 11.8. In a population with an HIV prevalence of 10%, about 40% of the smear-positive TB patients are attributable to HIV. The excess of TB cases in the entire country between 1982 and 1989 can be attributable to HIV infection. This has implications for TB control and socioeconomic consequences in the country.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Case Control Studies; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Infections; Measurement; Prevalence; Research Methodology; Studies; Tanzania; Tuberculosis; Viral Diseases

Mesh:

Year:  1995        PMID: 7672908     DOI: 10.1093/ije/24.3.637

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

1.  Surgery for small bowel perforation in an Asian population: predictors of morbidity and mortality.

Authors:  Ker-Kan Tan; Shieh-Ling Bang; Richard Sim
Journal:  J Gastrointest Surg       Date:  2009-12-09       Impact factor: 3.452

2.  The spectrum of abdominal tuberculosis in a developed country: a single institution's experience over 7 years.

Authors:  Ker-Kan Tan; Kenneth Chen; Richard Sim
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

3.  Trends in Hospitalisation for Human Immunodeficiency Virus in a Tertiary Hospital in Dar es Salaam, Tanzania: A Case study.

Authors:  Grace A Shayo; Tumaini Nagu; Lilian Msele; Patricia Munseri; Columba Mbekenga; Steven Kibusi; Kisali Pallangyo; Ferdinand Mugusi
Journal:  East Afr Health Res J       Date:  2020-06-26

4.  The prevalence of human immunodeficiency virus infection among TB patients in Port Harcourt Nigeria.

Authors:  O Erhabor; Z A Jeremiah; T C Adias; Ce Okere
Journal:  HIV AIDS (Auckl)       Date:  2010-01-14

5.  Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.

Authors:  Bruce J Kirenga; Willy Ssengooba; Catherine Muwonge; Lydia Nakiyingi; Stephen Kyaligonza; Samuel Kasozi; Frank Mugabe; Martin Boeree; Moses Joloba; Alphonse Okwera
Journal:  BMC Public Health       Date:  2015-01-21       Impact factor: 3.295

6.  Health workers' performance in the implementation of Patient Centred Tuberculosis Treatment (PCT) strategy under programmatic conditions in Tanzania: a cross sectional study.

Authors:  Abdallah Mkopi; Nyagosya Range; Mbaraka Amuri; Eveline Geubbels; Fred Lwilla; Saidi Egwaga; Alexander Schulze; Frank van Leth
Journal:  BMC Health Serv Res       Date:  2013-03-16       Impact factor: 2.655

7.  The magnitude and factors associated with delays in management of smear positive tuberculosis in Dar es Salaam, Tanzania.

Authors:  Sayoki G Mfinanga; Beatrice K Mutayoba; Amos Kahwa; Godfather Kimaro; Rugola Mtandu; Esther Ngadaya; Said Egwaga; Andrew Y Kitua
Journal:  BMC Health Serv Res       Date:  2008-07-27       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.